Long-term Follow-up of Hepatobiliary Fascioliasis: Serologic and Computed Tomography Findings

Background: Hepatobiliary fascioliasis (HF) is a significant public health concern. In humans, the diagnosis of fasciolosis typically relies on parasitological, immunological, and radiologic findings. Previous studies have documented long-term radiological findings post-treatment. However, there is insufficient data on the long-term follow-up of radiological results combined with anti-Fasciola antibody levels, which are crucial for diagnosing the disease. Objectives: This study aimed to evaluate the long-term laboratory findings, antibody levels, and radiological features following the treatment of patients with HF. Methods: This retrospective study included 25 patients with HF at Dicle University Medical Faculty Hospital from March 2009 to December 2015. Baseline and follow-up laboratory tests, anti-Fasciola antibody levels (mean follow-up: 43.0 ± 10.3 months post-treatment), and radiological results (mean follow-up: 37.9 ± 13.5 months post-treatment) were recorded. The follow-up results were compared with baseline data. Results: The study included 25 patients (20 female; mean age: 40.6 ± 11.7 years) diagnosed with HF. Significant changes were observed in eosinophil counts and Fasciola antibody levels. Antibody levels decreased in all patients, with antibody negativity developing in 40% (n = 10) of the patients. Biliary changes and intra-abdominal fluid resolved completely in all patients. Marked radiologic improvements were noted in lymphadenopathy, liver lesions, and splenomegaly. Both antibody negativity and radiological improvement were observed in 16% (n = 4) of the patients. No correlation was found between radiological improvement and antibody negativity or other parameters. Conclusions: In patients with HF, achieving antibody negativity and radiological improvement may require a prolonged period. During follow-up, radiological imaging and antibody levels should be interpreted cautiously in treated individuals whose laboratory tests, such as eosinophil count, are within the normal range.

Authors

Institutions

Publication Details

Journal
Hepatitis Monthly
Published
2025-02-22
DOI
https://doi.org/10.5812/hepatmon-144963
Primary Topic
Helminth infection and control
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-term Follow-up of Hepatobiliary Fascioliasis: Serologic and Computed Tomography Findings

Feyzullah Uçmak, Hüseyin Kaçmaz, İbrahim Akbudak, Nazım Ekin et al.
Hepatitis Monthly
Helminth infection and control
article

Long-term Follow-up of Hepatobiliary Fascioliasis: Serologic and Computed Tomography Findings

Feyzullah Uçmak, Hüseyin Kaçmaz, İbrahim Akbudak, Nazım Ekin, Muhsin Kaya
article en

Abstract

Background: Hepatobiliary fascioliasis (HF) is a significant public health concern. In humans, the diagnosis of fasciolosis typically relies on parasitological, immunological, and radiologic findings. Previous studies have documented long-term radiological findings post-treatment. However, there is insufficient data on the long-term follow-up of radiological results combined with anti-Fasciola antibody levels, which are crucial for diagnosing the disease. Objectives: This study aimed to evaluate the long-term laboratory findings, antibody levels, and radiological features following the treatment of patients with HF. Methods: This retrospective study included 25 patients with HF at Dicle University Medical Faculty Hospital from March 2009 to December 2015. Baseline and follow-up laboratory tests, anti-Fasciola antibody levels (mean follow-up: 43.0 ± 10.3 months post-treatment), and radiological results (mean follow-up: 37.9 ± 13.5 months post-treatment) were recorded. The follow-up results were compared with baseline data. Results: The study included 25 patients (20 female; mean age: 40.6 ± 11.7 years) diagnosed with HF. Significant changes were observed in eosinophil counts and Fasciola antibody levels. Antibody levels decreased in all patients, with antibody negativity developing in 40% (n = 10) of the patients. Biliary changes and intra-abdominal fluid resolved completely in all patients. Marked radiologic improvements were noted in lymphadenopathy, liver lesions, and splenomegaly. Both antibody negativity and radiological improvement were observed in 16% (n = 4) of the patients. No correlation was found between radiological improvement and antibody negativity or other parameters. Conclusions: In patients with HF, achieving antibody negativity and radiological improvement may require a prolonged period. During follow-up, radiological imaging and antibody levels should be interpreted cautiously in treated individuals whose laboratory tests, such as eosinophil count, are within the normal range.

Hepatitis MonthlyVol. 25(1)
Dicle University (TR)
Openalex Percentile: Top 96%
Helminth infection and control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.